Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Former FDA Official Calls For 483 Reforms, Notes Caveats

Aug 22 2018

• By Derrick Gingery

factory production, process, industry

Related Content

Will FDA GMP Observations Stall Biocon’s Run?

Aug 07 2017

FDA Accelerates Inspection Process With New Concept Of Operations

Aug 25 2017

US FDA Urged To Rethink Warning Letters To Avoid ‘Collateral Damage’

May 22 2017

FDA Aligns New Pharmaceutical Inspectorate Into Six Divisions

May 17 2017

FDA Warns Apotex Management To Demand Quality, Meet Specs

Aug 17 2018

After Issuing 40 Drug GMP Warning Letters in FY 2012, FDA Aims to Improve Drug Quality This Year

Mar 28 2013

Sun Hit As US FDA Raises Fresh Concerns Over Key Halol Plant

Dec 08 2016

Senate's Medical Innovation Bill Takes Cures' Shape

Apr 06 2016

What FDA Inspection Trends Really Mean

Nov 20 2015

Related Companies

Sun Pharmaceutical Industries Ltd.

Biocon, Ltd.

Additional Topics

United States Manufacturing Compliance Regulation FDA BioPharmaceutical

More from Manufacturing

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window